文献速递胸部肿瘤放疗放疗物理与技术

纵隔淋巴瘤或肺癌患者心脏亚结构的分次内位移研究

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer.
PubMed 文献 · Adv Radiat Oncol · 2019-03-29

该回顾性研究纳入20例纵隔淋巴瘤或肺癌患者,利用4DCT评估自由呼吸下心脏亚结构的分次内位移。结果显示各亚结构质心位移为0.7-1.5 cm,以头脚方向最显著;淋巴瘤患者右心室、主动脉瓣和左前降支位移显著更大,肺癌患者则在X和Y方向位移更明显。

要点

  • 心脏亚结构分次内位移为0.7-1.5 cm,头脚方向最显著。
  • 淋巴瘤患者右心室、主动脉瓣、左前降支位移显著更大。
  • 肺癌患者在X和Y方向位移更明显。

核心结论

  • 心脏亚结构分次内位移范围为0.7-1.5 cm,主要沿Z方向(头脚方向)。
  • 淋巴瘤与肺癌患者总体位移无统计学显著差异,但特定亚结构位移方向存在差异。

研究设计与样本

  • 回顾性分析20例患者(12例纵隔淋巴瘤,8例肺癌)的医学记录,均接受4DCT模拟定位和增强扫描用于治疗计划。
  • 在50%相位勾画心脏、冠状动脉、心腔和瓣膜,并传播至其他相位后编辑;对每个亚结构勾画难度评分(1=无困难至4=非常困难)。
  • 导出各相位亚结构质心位置和体积,计算基本统计量并进行独立t检验。

主要发现

  • 心脏、4个心腔和房室瓣平均勾画难度评分为1-1.2,肺动脉瓣、左前降支、主动脉瓣、回旋支和右冠状动脉为2.1-3.2。
  • 4个心腔及二尖瓣、肺动脉瓣质心位移最小(0.7-1.1 cm)。
  • 冠状动脉血管及三尖瓣、主动脉瓣位移较大(1.2-1.5 cm)。
  • 所有亚结构位移在Z方向最大;淋巴瘤患者右心室、主动脉瓣和左前降支位移显著大于肺癌患者(P < .05)。
  • 肺癌患者右心房、三尖瓣、右心室和心脏在X和Y方向位移显著更大;总体位移在两组间无统计学显著差异。

关键数值与推荐

  • 勾画难度评分:1=无困难,2=轻微困难,3=中度困难,4=非常困难。
  • 质心位移范围:心腔及二尖瓣/肺动脉瓣0.7-1.1 cm,冠状动脉及三尖瓣/主动脉瓣1.2-1.5 cm。
  • 淋巴瘤患者右心室、主动脉瓣、左前降支位移显著更大(P < .05)。
  • 肺癌患者右心房、三尖瓣、右心室和心脏在X和Y方向位移显著更大。

临床怎么用

  • 放疗计划设计时应考虑心脏亚结构的分次内位移,尤其是头脚方向。
  • 对淋巴瘤和肺癌患者,需关注不同亚结构的位移方向差异,可能需个体化运动管理。
  • 勾画心脏亚结构时需注意冠状动脉和瓣膜的难度较高。

局限性

  • 回顾性研究,样本量较小(20例)。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The radiation dose to specific substructures of the heart may be more critical than the dose to the whole heart. Yet, these substructures are sensitive to intrafractional motion from breathing and cardiac motion, which can affect their dose-volume histograms. We sought to investigate intrafractional motion of the heart and its substructures among free-breathing patients undergoing radiation for mediastinal lymphoma or lung cancer. METHODS AND MATERIALS: After institutional review board approval, the medical records of 20 patients (12 with mediastinal lymphoma; 8 with lung cancer) were retrospectively reviewed. Patients underwent 4-dimensional computed tomography simulation and a contrasted scan for treatment planning. Using MIMVista software, the heart, coronary arteries, chambers, and valves were contoured on the 50% phase, and these contours were propagated to the other phases and edited. Each substructure was graded on the basis of its ease of contouring across all phases (1 = no difficulty; 2 = minor difficulty; 3 = moderate difficulty; and 4 = very difficult). The centroid position and volume of each substructure for all phases were exported to Excel to calculate basic statistics and the independent t test. RESULTS: The heart, 4 chambers, and atrioventricular valves were easily identified with a mean score of 1 to 1.2, and the pulmonic valve, left anterior descending artery, aortic valve, circumflex, and right coronary artery were minor-to-moderately difficult with a mean score of 2.1 to 3.2. The smallest centroid displacement was seen in the 4 chambers and mitral and pulmonic valves (0.7-1.1 cm). Greater displacement was seen in the coronary vessels and tricuspid and aortic valves (1.2-1.5 cm). The greatest displacement was in the Z direction (craniocaudal) for all substructures; however, the displacement was significantly greater among patients with lymphoma for the right ventricle, aortic valve, and left anterior descending artery (P < .05). However, patients with lung cancer had more displacement in the X and Y directions, which was statistically significant for the right atrium, tricuspid valve, right ventricle, and heart. When calculating overall displacement, no statistically significant difference was observed between patients with lymphoma and patients with lung cancer. CONCLUSIONS: Intrafractional motion of the cardiac substructures ranged from 0.7 to 1.5 cm, mostly in the Z direction. Further investigation of the respiratory motion effect on the dose-volume histogram of the substructures is needed for patients treated with contemporary radiation techniques.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Guzhva L, Flampouri S, Mendenhall NP, et al. Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer. Adv Radiat Oncol. 2019. PMID: 31360806. doi:10.1016/j.adro.2019.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。